Literature DB >> 9692544

Retinoic acid receptors and muscle b-HLH proteins: partners in retinoid-induced myogenesis.

A Froeschlé1, S Alric, M Kitzmann, G Carnac, F Auradé, C Rochette-Egly, A Bonnieu.   

Abstract

The results reported here indicate that retinoic acid (RA) induces growth arrest and differentiation only in MyoD-expressing muscle cells. Transient transfection assays reveal a functional interaction between MyoD, a key myogenic regulator and RA-receptors, principal mediators of RA actions. Interestingly, we demonstrate that RXR-MyoD-containing complexes are recruited at specific MyoD DNA-binding sites in muscle cells. Furthermore, we also demonstrate that RA-receptors and the muscle basic helix-loop-helix (b-HLH) proteins interact physically. Mutational analysis suggests that this interaction occurs via the basic region of muscle b-HLH proteins and the DNA-binding domain of RA-receptors and is important for functional interactions between these two families of transcription factors. In conclusion, these results highlight novel interactions between two distinct groups of regulatory proteins that influence cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692544     DOI: 10.1038/sj.onc.1201894

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Functional interaction between peroxisome proliferator-activated receptors-alpha and Mef-2C on human carnitine palmitoyltransferase 1beta (CPT1beta) gene activation.

Authors:  Angel Baldán; Joana Relat; Pedro F Marrero; Diego Haro
Journal:  Nucleic Acids Res       Date:  2004-09-08       Impact factor: 16.971

2.  Retinoid signaling and neurogenin2 function are coupled for the specification of spinal motor neurons through a chromatin modifier CBP.

Authors:  Seunghee Lee; Bora Lee; Jae W Lee; Soo-Kyung Lee
Journal:  Neuron       Date:  2009-06-11       Impact factor: 17.173

3.  Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repair.

Authors:  Joseph B Vella; Seth D Thompson; Mark J Bucsek; Minjung Song; Johnny Huard
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

4.  Genome-wide Twist1 occupancy in endocardial cushion cells, embryonic limb buds, and peripheral nerve sheath tumor cells.

Authors:  Mary P Lee; Nancy Ratner; Katherine E Yutzey
Journal:  BMC Genomics       Date:  2014-09-28       Impact factor: 3.969

5.  ERK1/2 inhibition promotes robust myotube growth via CaMKII activation resulting in myoblast-to-myotube fusion.

Authors:  Tamar Eigler; Giulia Zarfati; Emmanuel Amzallag; Sansrity Sinha; Nadav Segev; Yishaia Zabary; Assaf Zaritsky; Avraham Shakked; Kfir-Baruch Umansky; Eyal D Schejter; Douglas P Millay; Eldad Tzahor; Ori Avinoam
Journal:  Dev Cell       Date:  2021-12-20       Impact factor: 12.270

6.  Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin.

Authors:  Karen A M Kennedy; Tammy Porter; Virja Mehta; Scott D Ryan; Feodor Price; Vian Peshdary; Christina Karamboulas; Josée Savage; Thomas A Drysdale; Shun-Cheng Li; Steffany A L Bennett; Ilona S Skerjanc
Journal:  BMC Biol       Date:  2009-10-08       Impact factor: 7.364

7.  Hedgehog signaling regulates MyoD expression and activity.

Authors:  Anastassia Voronova; Erin Coyne; Ashraf Al Madhoun; Joel V Fair; Neven Bosiljcic; Catherine St-Louis; Grace Li; Sherry Thurig; Valerie A Wallace; Nadine Wiper-Bergeron; Ilona S Skerjanc
Journal:  J Biol Chem       Date:  2012-12-24       Impact factor: 5.157

8.  Aldehyde dehydrogenases contribute to skeletal muscle homeostasis in healthy, aging, and Duchenne muscular dystrophy patients.

Authors:  Jessy Etienne; Pierre Joanne; Cyril Catelain; Stéphanie Riveron; Alexandra Clarissa Bayer; Jérémy Lafable; Isabel Punzon; Stéphane Blot; Onnik Agbulut; Jean-Thomas Vilquin
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-10       Impact factor: 12.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.